Locations:

Research

September 20, 2017/Cancer/Research

When Concurrent Chemoradiotherapy Makes Sense for Older Patients

Postsurgery chemo for certain head and neck cancers

August 14, 2017/Cancer/Research

Ki67 Protein Levels Predict Which Breast Cancer Patients Respond to Endocrine Therapy

A recent clinical trial tested neoadjuvant therapies

August 4, 2017/Cancer/Research

Neratinib FDA Approval for Extended Adjuvant Therapy a Win for HER2+ Patients

Safe, effective, welcome option

July 5, 2017/Cancer/Research

Circulating Cell-Free Genome Atlas Study Aims to Detect Cancer Before Symptoms Occur

Deep sequencing may help map cancer genetics

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 29, 2017/Cancer/Research

Non-Cytotoxic Epigenetic Therapy for p53-Mutant/p16-Deleted Solid and Liquid Cancers

Three clinical trials underway

June 19, 2017/Cancer/Research

Study Warns Against De-Intensifying Treatment for Certain Oropharyngeal Cancer Patients

Not all HPV-positive patients have good prognoses

June 5, 2017/Cancer/Research

Time to Treat is Increasing, Associated with Worsened Survival

Cleveland Clinic study of 3.7 million patients

June 5, 2017/Cancer/Research

Study Suggests Some Small Cell Lung Cancer Patients Benefit from Immune Checkpoint Inhibitor

Pembrolizumab stabilizes cancer in some patients

June 5, 2017/Cancer/Research

Trial Finds Maximum Tolerable Dose for Combination Therapy for Metastatic Renal Cell Carcinoma Patients

Axitinib and crizotinib stabilized disease in most

June 4, 2017/Cancer/Research

Maximum Tolerable Doses for Adding Cell Checkpoint Inhibitor to Standard of Care for Glioblastoma Patients

Inhibitor stops DNA repair of cancer cells

BackPage 25 of 27Next